U.S. FDA

Our posts are FDA Approved!
Privacy Policy -
FDA Authentic Accounts -

[U.S. FDA @FDA]

This #DrugTakeBackDay, take a few minutes to check your medicine cabinet. Unused #opioids don't need to be saved "just in case."

Safe disposal protects your whole family, especially your teens.

🗓 Saturday, October 24 | 10 a.m. - 2:00 p.m.

📍 Find a convenient, confidential drop-off location near you: https://t.co/XXcz0uOoWm

[DEA HQ @DEAHQ]

Gather all unneeded, unused or expired medications for #DEATakeBackDay. Safely dispose of them at one of the 4,200 drop-off locations to prevent misuse and protect our communities. #TakeBackDay https://t.co/4fnmPFbQyo

@TheJusticeDept

[U.S. FDA @FDA]

🦴 Strong bones support healthy aging. On #WorldOsteoporosisDay, learn how FDA-approved biosimilars may be an option for some bone-related conditions, including certain forms of osteoporosis:

Learn more: https://t.co/OANBOeoM5M

[U.S. FDA @FDA]

https://t.co/uXIjOmcW1n

[U.S. FDA @FDA]

Food fraud can cost consumers more than money—it can undermine confidence in what’s on the label. FDA testing of 195 domestic and import samples of lemon juice found 7 imported products that did not meet the U.S. standard of identity for lemon juice. This work builds on recent FDA sampling to detect economically motivated adulteration in foods including honey and seafood. Learn more about the results of FDA’s testing of lemon juice samples.

[U.S. FDA @FDA]

This #BreastCancerAwarenessMonth, pink ribbons come with real reason for hope. In the past year alone, FDA approved 10 new breast cancer treatments. The FDA is working every day to get life-saving breakthroughs to patients faster. https://t.co/tsR9dgbo3l

[U.S. FDA @FDA]

Learn more: https://t.co/uQit12Xb6N

[U.S. FDA @FDA]

⚠️ FDA is warning consumers about counterfeit OTC eye drops found in Florida and Georgia, with possible distribution in other states. Some products tested positive for bacterial contamination, posing risks of eye infections, injury, and vision problems. FDA is working to identify and remove unlawful products.

[FDA Drugs and Biologics @FDADrugs]

The FDA today launched the Rare Disease Framework Initiative to reimagine rare disease drug development.

The new framework will adapt aspects of the agency’s long-standing approach designed for larger diseases. It will adopt an optimized, fit-for-purpose framework for rare disease drug development that considers the nuances of a specific disease, patient needs, product type, and attainable evidence. https://t.co/cngtfmvdMv

FDA will host a meeting on Oct. 28 at the White Oak campus to collect feedback on the Rare Disease Framework Initiative from patients, disease advocates, industry, and other stakeholders. https://t.co/0ynT0EXG0s

[U.S. FDA @FDA]

FDA is transforming rare disease drug approvals. The new Rare Disease Framework Initiative will work to give patients more voice, give developers more clarity, and eliminate surprises in the regulatory process. https://t.co/dN9mby7MPN

[FDA Drugs and Biologics @FDADrugs]

FDA’s #PrescribeWithConfidence campaign supports the Trump Administration’s Great American Recovery Initiative by helping expand access to evidence-based treatment for #OpioidUseDisorder. https://t.co/1ff2aWGGBR

Watch the final four videos in the 10-part series featuring nurse practitioner Amy Techau: https://t.co/HEkXWCFtZ0

[FDA Medical Devices @FDADevices]

Don't miss this! Register today for the FDA Grand Rounds on Oct. 22. CDRH experts will take you inside FDA's Real-World Evidence Program & its role in digital health technology. Attend in person or tune in via webcast. https://t.co/mLcHmJn2W7

[U.S. FDA @FDA]

Consumers, parents, and caregivers should stop using any product from Lot 25122bw and either discard it or return it to the place of purchase for a refund.

[U.S. FDA Recalls and Alerts @FDArecalls]

Pacific Health Sciences Voluntarily Recalls One Lot of Babies' Magic Tea Brand Baby Sleep Gripe Water Dietary Supplement

MORE: https://t.co/OVwu3jrVTx

[U.S. FDA @FDA]

Join us! We’re conducting a nationwide search to find scientific experts and consumer voices to fill vacancies on our advisory committees. Want to help us make informed decisions about public health? Apply today! https://t.co/erzPjQPWw9

[U.S. FDA @FDA]

As Acting Commissioner Diamantas and Director Davis write, "it stands as a decisive victory for veterans and a clear testament to an administration committed to helping patients and researchers navigate complex study approaches in the relentless pursuit of medical innovation."

[U.S. FDA @FDA]

In an article published today, Acting FDA Commissioner Kyle Diamantas and CDER Director Mike Davis discuss an action taken by FDA and the Trump administration to ensure that America's warfighters have access to cutting-edge, lifesaving care. https://t.co/vKR9olSh0J

[U.S. FDA @FDA]

The Request for Information released yesterday opens the door for public and expert perspectives as FDA works toward early-stage clinical trials for ibogaine drug products, marking a meaningful step in bringing these products forward.

[U.S. FDA @FDA]

Learn more about the outbreak investigation: https://t.co/bhnbc1pbti and FDA’s ongoing prevention efforts: https://t.co/MAJ1YY7H4b

[U.S. FDA @FDA]

The FDA is taking decisive action to prevent future Cyclospora outbreaks with the advancement of 10 planned activities ahead of the 2027 growing season to strengthen prevention, enhance surveillance, expand industry outreach, and identify innovative solutions to reduce Cyclospora contamination of fresh produce.

[U.S. FDA @FDA]

Transparency isn't just good government — it's how we accelerate innovation and protect public health. Today, FDA released its new Transparency Roadmap, outlining FY26 milestones and FY27 priorities: CRL disclosure, NAMs, food labeling, inspections, and more. https://t.co/PtcHga1h1n